Tonix Pharmaceuticals Holding Corp. (50) | Business Finance (31)
Browse by Subcategory
Recent Contracts
-
Registration Rights Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on December 3, 2021)
-
Purchase Agreement, dated December 3, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on December 3, 2021)
-
Assignment and Agreement, dated June 11, 2020, between the Company and The Board of Trustees of the Leland Stanford Junior University
(Filed With SEC on August 10, 2020)
-
Form of Warrant Agency Agreement
(Filed With SEC on February 6, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on February 6, 2020)
-
Purchase and Sale Agreement, dated July 26, 2021, between the Company and Southern Research
(Filed With SEC on August 9, 2021)
-
Registration Rights Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on May 14, 2021)
-
Purchase Agreement, dated May 14, 2021, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on May 14, 2021)
-
Purchase and Sale Agreement, dated March 5, 2021, between Tonix Pharmaceuticals Holding Corp. and the Seller named therein
(Filed With SEC on March 15, 2021)
-
Form of Securities Purchase Agreement, dated February 8, 2021, by and between the Company and the Purchasers thereunder
(Filed With SEC on February 9, 2021)
-
Form of Securities Purchase Agreement, dated January 11, 2021, by and between the Company and the Purchasers thereunder
(Filed With SEC on January 12, 2021)
-
Purchase and Sale Agreement, dated October 14, 2020
(Filed With SEC on November 9, 2020)
-
Registration Rights Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on September 4, 2020)
-
Purchase Agreement, dated September 3, 2020, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on September 4, 2020)
-
Asset Purchase Agreement, dated June 11, 2020, between the Company and Trigemina, Inc
(Filed With SEC on August 10, 2020)
-
Purchase and Sale Agreement, dated July 1, 2020
(Filed With SEC on August 10, 2020)
-
Form of Securities Purchase Agreement, dated July 13, 2020, by and between the Company and the Purchasers thereunder
(Filed With SEC on July 14, 2020)
-
Form of Securities Purchase Agreement, dated February 28, 2020, by and between the Company and the Purchasers thereunder
(Filed With SEC on February 28, 2020)
-
Form of Warrant
(Filed With SEC on February 6, 2020)
-
Form of Common Warrant
(Filed With SEC on November 15, 2019)
-
Form of Warrant
(Filed With SEC on November 15, 2019)
-
Form of Warrant Agreement
(Filed With SEC on November 14, 2019)
-
Form of Warrant Agency Agreement
(Filed With SEC on November 14, 2019)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on November 14, 2019)
-
Form of Warrant
(Filed With SEC on November 14, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on November 14, 2019)
-
Asset Purchase Agreement, dated August 19, 2019, between Tonix Pharmaceuticals Holding Corp. and TRImaran Pharma, Inc
(Filed With SEC on November 8, 2019)
-
Registration Rights Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on August 23, 2019)
-
Purchase Agreement, dated August 20, 2019, by and between Tonix Pharmaceuticals Holding Corp. and Lincoln Park Capital Fund, LLC
(Filed With SEC on August 23, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on July 15, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on July 11, 2019)